Mandy Beyer

Mainz, RP, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

The Host Cell Factor Phosphatase-2A Subunit PR130 Restricts Replication of Herpes Simplex Virus Type-1.

The Host Cell Factor Phosphatase-2A Subunit PR130 Restricts Replication of Herpes Simplex Virus Type-1.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: November 22, 2025

Histone deacetylase inhibitors modulate hormesis in leukemic cells with mutant FMS-like tyrosine kinase-3.

Histone deacetylase inhibitors modulate hormesis in leukemic cells with mutant FMS-like tyrosine kinase-3.

Journal: Leukemia

Published: March 28, 2023

Colony Formation Assay to Test the Impact of HDACi on Leukemic Cells.

Colony Formation Assay to Test the Impact of HDACi on Leukemic Cells.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: October 18, 2022

RNA interference protocol to silence oncogenic drivers in leukemia cell lines.

RNA interference protocol to silence oncogenic drivers in leukemia cell lines.

Journal: STAR protocols

Published: March 30, 2022

News and views : AUTOTACs join the arena for targeted protein degradation.

News and views : AUTOTACs join the arena for targeted protein degradation.

Journal: Archives of toxicology

Published: March 27, 2022

Targeting the MYC interaction network in B-cell lymphoma via histone deacetylase 6 inhibition.

Targeting the MYC interaction network in B-cell lymphoma via histone deacetylase 6 inhibition.

Journal: Oncogene

Published: February 12, 2022

Global metabolic alterations in colorectal cancer cells during irinotecan-induced DNA replication stress.

Global metabolic alterations in colorectal cancer cells during irinotecan-induced DNA replication stress.

Journal: Cancer & metabolism

Published: January 11, 2022

Inhibitors of class I HDACs and of FLT3 combine synergistically against leukemia cells with mutant FLT3.

Inhibitors of class I HDACs and of FLT3 combine synergistically against leukemia cells with mutant FLT3.

Journal: Archives of toxicology

Published: June 21, 2021

Mechanistic insights into p53-regulated cytotoxicity of combined entinostat and irinotecan against colorectal cancer cells.

Mechanistic insights into p53-regulated cytotoxicity of combined entinostat and irinotecan against colorectal cancer cells.

Journal: Molecular oncology

Published: May 22, 2021

Identification of a highly efficient dual type I/II FMS-like tyrosine kinase inhibitor that disrupts the growth of leukemic cells.

Identification of a highly efficient dual type I/II FMS-like tyrosine kinase inhibitor that disrupts the growth of leukemic cells.

Journal: Cell chemical biology

Published: April 07, 2021

A series of novel aryl-methanone derivatives as inhibitors of FMS-like tyrosine kinase 3 (FLT3) in FLT3-ITD-positive acute myeloid leukemia.

A series of novel aryl-methanone derivatives as inhibitors of FMS-like tyrosine kinase 3 (FLT3) in FLT3-ITD-positive acute myeloid leukemia.

Journal: European journal of medicinal chemistry

Published: November 04, 2019

HDAC3 Activity is Essential for Human Leukemic Cell Growth and the Expression of β-catenin, MYC, and WT1.

HDAC3 Activity is Essential for Human Leukemic Cell Growth and the Expression of β-catenin, MYC, and WT1.

Journal: Cancers

Published: August 16, 2019

Showing 1-12 of 20

Last Updated: 09/26/2026